Silver Valley Pharmaceuticals Class 1 new drug benzene ring ammonium bromide nasal spray is about to be approved

Allergic rhinitis, also known as allergic rhinitis, refers to the specific individual contact allergen, mainly by IgE-mediated media (mainly histamines) release, and has a variety of immune active cells and cytokines and other involved in the nasal mucosal non-infectious inflammatory diseases, mainly manifested as a burst of sneezing, water-like nasal snot, nasal congestion and nasal itchAs one of the major respiratory chronic inflammatory diseases in China, the prevalence of allergic rhinitis has risen rapidly in recent years, according to statistics, about 150 million adults in China are suffering from rhinitis, of which more than 6 million patients with moderate and severe allergic rhinitiscommon treatment drugs for allergic rhinitis include glucocorticoids, antihistamines, hypercell stabilizers, blood-reducing agents, anticholinergics, among which antihistamines are the most commonThe dosage forms of allergic rhinitis drugs include oral preparations, nasal preparations, etc, wherein the nasal preparations directly act on the drug site, the effect is fast, and less than oral administration side effectsin April 2014, Yingu Pharmaceuticals first submitted a domestic application for the listing of ammonium phenylcycloryphiaquina and its nasal spray, but then voluntarily withdrew its listing application in 2015 during the "722" clinical trial self-examination verificationIn 2017, Gu'an Shiqiao Pharmaceuticals and Silver Valley Pharmaceuticals jointly submitted a listing application for ammonium phenyl-chloroquine and its nasal spray, which was included in the priority review by CDE in 2018in addition,, the Insight database shows that aerosol stoics inhaled with ammonium phenyobium bromide are being clinically tested for chronic obstructive pulmonary disease (COPD)the company's current products are salmon calcinic injection (Guteninin) and its nasal spray (Kinli), a calcium regulator, mainly for osteoporosis, hypercalcemia and metamorphic osteoarthritisthe following image shows the review time timeline of the benzene-ring ammonium bromide nasal spray (source: https://db.dxy.cn/)(Note: original lying)original title: 722 clinical verification has been withdrawn, this domestic class 1 new drug is about to be approved